Literature DB >> 33105138

Influence of Consanguinity and Medication on the Development of Parkinson's Disease.

Muhammad Tufail1, Ishtiaq Hassan2.   

Abstract

INTRODUCTION: Parkinson's disease is the second most common neurodegenerative disease. The disease is more prevalent in aged individuals compared to young ones. AIM: The present study aimed to investigate the factors associated with PD in the population of Khyber Pakhtunkhwa, Pakistan.
METHODS: In this study, the questionnaire was filled from 600 PD patients, which include 54 familial cases, and 1,200 control subjects. To study the risk of PD in familial cases, questionnaires were also filled from the cases and controls.
RESULTS: This study revealed that depression symptomology is common in PD patients. Moreover, the risk of PD was higher in patients with consanguineous marriages compare to controls (OR = 3.96, 95% Cl = 1.98-7.89). The first-degree relatives (59.3%) of PD patients are more likely to develop PD compared to a second- (29.5%) or third-degree (11.1%) relatives. Furthermore, the risk of PD is higher in individuals whose parents get married to first-cousin (OR: 4.76, 95% Cl: 1.81-12.5) than second- (OR: 1.34, 95% Cl: 0.54-3.32) or third-cousin marriages (OR = 0.18, 95% Cl: 0.06-0.49). Moreover, the use of paracetamol (OR: 0.39; 95% Cl: 0.25-0.59) and ibuprofen (OR: 0.35; 95% Cl: 0.17-0.70) were higher in control subjects.
CONCLUSION: This study concludes that consanguineous marriages and first-degree relation with PD patients increase the risk of PD, while the use of certain medications may decrease the risk of PD. Further study is warranted in a population of Pakistan.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Consanguineous marriages; Depression symptomology; Familial PD; Medicine use; Parkinson’s disease

Mesh:

Substances:

Year:  2020        PMID: 33105138     DOI: 10.1159/000509586

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  1 in total

1.  Psychological impact of COVID-19 pandemic on Parkinson's disease patients.

Authors:  Muhammad Tufail; Changxin Wu
Journal:  Heliyon       Date:  2022-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.